Hematologist Ruben Mesa, M.D., Chair, Division of Hematology and Oncology at Mayo Clinic in Arizona, provides an update on Myeloproliferative Neoplasms
Dr. Ibrahim Haznedaroglu discusses how myeloproliferative neoplasms (MPNs) develop.
© 2011 Novartis AG